Dong Bang Co Ltd to Showcase Veterinary Pharmaceuticals at Indo Livestock 2026

2026-06-05 13:00
Dong Bang Co Ltd to Showcase Veterinary Pharmaceuticals at Indo Livestock 2026
Dong Bang Co Ltd to Showcase Veterinary Pharmaceuticals at Indo Livestock 2026

SEOUL, South Korea, June 5, 2026 /PRNewswire/ -- Dong Bang Co Ltd, a Korean veterinary pharmaceutical manufacturer, will participate in the "Indo Livestock 2026 Expo & Forum," which will be held in Jakarta, Indonesia, from June 16 to 18, as part of its global market expansion strategy.

Founded in 1983, Dong Bang Co Ltd has specialized in the production of veterinary pharmaceuticals for livestock and companion animals, including cattle, pigs, poultry, and pets. The company develops a wide range of products designed to support animal health and safe livestock production, including probiotics, hormones, antibiotics, pet anesthetics, and natural antiviral agents.

Through continuous R&D investment and global partnerships, the company has expanded its export presence across Southeast Asia, the Middle East, CIS countries, and Central Asia.

At the exhibition, Dong Bang Co Ltd plans to introduce its updated product lineup to existing overseas partners and potential buyers. The company will particularly highlight pet anesthetics, newly launched canine probiotics, and anti-inflammatory pain relief products, which are in high demand in Southeast Asian markets.

Dong Bang Co Ltd stated that the exhibition will serve as an opportunity to strengthen its global brand recognition and expand its overseas business network. The company also emphasized its proprietary manufacturing technology for livestock reproductive hormones, noting that it is the only company in Korea with in-house production capabilities in this field.

A company official said, "This exhibition will be an important opportunity to introduce our long-standing R&D achievements to the global market and further strengthen the competitiveness of Korean veterinary pharmaceuticals." (Related: ENERtec Asia 2026 Opens Amid Rising Focus on Energy Infrastructure for AI and Data Centre Growth Latest

The company added that it will continue developing high-quality veterinary healthcare products in line with the global 'One Health' trend, which emphasizes the interconnected health of humans, animals, and the environment.

Latest
VEVOR Launches Five Summer Products at Houston Store, Bringing "Upgrade Firsthand" to Local Home Creators
ENERtec Asia 2026 Opens Amid Rising Focus on Energy Infrastructure for AI and Data Centre Growth
Rezonate Raises US$5 Million and Unveils New Brand Identity to Accelerate U.S. Expansion
Pentagon weighs $1.85 billion plan to build US Navy warships in South Korea and Japan
Taiwan's Ennostar, TSMC Bet on Micro LED to Power Nvidia's AI Clusters
Samsung EOFY offer frenzy begins with its ground-breaking Galaxy S26 Ultra slashing upwards of $400 for limited time only
Intel's CEO Takes On NVIDIA and AMD at Computex With a Roadmap, Not a Price War
Exclusive | A Nobel Laureate's Warning: AI Overpromises, Underdelivers — and Kills Creativity
Herbalgy "TO-Go" Summer Treat: Keung To-Themed Gelato Truck
Osara Health Expands Into Survivorship Care, Strengthening Cancer Support Beyond Treatment
Kiwi-Born Legal AI Company Ivo Partners with New Zealand Football as Global Expansion Accelerates
Notabene Flow Activates Hundreds of Customers, Enabling Stablecoin B2B Payments Across the Globe
Tishman Speyer Secures $300 Million First Close for Korea Living Venture with APG and Bouwinvest
Meshy Launches 3D Agent Beta, the World's First AI Agent for 3D Creation
Primax Advances AI Conference Solutions with Qualcomm-Powered Edge AI Platforms
New Brandwatch Research Reveals the 'Question Gap' Between Search Intent and Social Context
MegazoneCloud Deploys Multi-Agent AI Shopping Agent for Golfzon Commerce
Ocean Tomo, a Part of J.S. Held, Experts Named to the 2026 IAM Patent 1000
Global Ergothioneine Market Poised for Accelerated Growth as Scientific Validation and Synthetic Biology Reshape Industry Dynamics